Home » Horiba Biotechnology, Toyama University, National Institute of Advanced Industrial Science and Technology, Gene-IT, MiraiBio, National Institutes of Health

Horiba Biotechnology, Toyama University, National Institute of Advanced Industrial Science and Technology, Gene-IT, MiraiBio, National Institutes of Health

Dec 08, 2004
Premium

Japanese firm Horiba Biotechnology has developed a DNA biosensor using a charge-coupled device. The firm collaborated with Toyama University and the National Institute of Advanced Industrial Science and Technology in developing the biosensor. Horiba said it would seek to commercialize the biosensor for gene-detection and gene-expression applications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Testing Less Likely

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three for Immunotherapy

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

This Week in Genome Research

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Cancer-Fighting Zombies

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

What's Popular?

In Microarrays & Multiplexing

  1. Broad Institute, Mass General Team Develops Polygenic Risk Scores for Five Common Diseases

  2. Endometrial Cancer Meta-Analysis Leads to New Risk Variants, Causal Gene Candidates

  3. Pathogen Response-Related Variants Tapped for Broader Disease Insights

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.